Keyphrases
Gene Therapy
100%
Mouse Model
100%
Viral
100%
CASQ2
100%
Catecholaminergic Polymorphic Ventricular Tachycardia
100%
Sustained Ventricular Tachycardia
25%
Knock-in Mouse Model
16%
Murine Model
16%
Antiarrhythmic Efficacy
16%
Nonsustained Ventricular Tachycardia
16%
Stress-induced
8%
Adenovirus
8%
Expression Level
8%
Risk Reduction
8%
Aged Mice
8%
Protein Level
8%
Sudden Death
8%
Transgene Expression
8%
Virus-like Particles
8%
Arrhythmia
8%
Human mutations
8%
Calsequestrin
8%
Protein S Deficiency
8%
Premature Ventricular Contraction
8%
Systemic Delivery
8%
Provocation Test
8%
Telemetry Device
8%
Intraperitoneal Therapy
8%
Biochemistry, Genetics and Molecular Biology
Mouse Model
100%
Gene Therapy
100%
Catecholaminergic Polymorphic Ventricular Tachycardia
100%
Mouse
71%
Ventricular Tachycardia
71%
Knockout Mouse
28%
Antiarrhythmic Agent
28%
Transgene
14%
Virus Particle
14%
Adeno Associated Virus
14%
Calsequestrin
14%
Cardiac Dysrhythmia
14%
Premature Ventricular Contraction
14%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Model
100%
Catecholaminergic Polymorphic Ventricular Tachycardia
100%
Mouse
71%
Heart Ventricle Tachycardia
71%
Knockout Mouse
28%
Antiarrhythmic Agent
28%
Adeno Associated Virus
14%
Heart Arrhythmia
14%
Sudden Death
14%
Calsequestrin
14%
Heart Ventricle Extrasystole
14%
Protein Deficiency
14%
Medicine and Dentistry
Gene Therapy
100%
Catecholaminergic Polymorphic Ventricular Tachycardia
100%
Sustained Ventricular Tachycardia
42%
Antiarrhythmic Agent
28%
Nonsustained Ventricular Tachycardia
28%
Virus Particle
14%
Cardiac Dysrhythmia
14%
Sudden Death
14%
Adeno-Associated Virus
14%
Calsequestrin
14%
Premature Ventricular Contraction
14%
Protein Deficiency
14%
Transgene
14%
Veterinary Science and Veterinary Medicine
Mouse
100%
Catecholaminergic Polymorphic Ventricular Tachycardia
100%
Ventricular Tachycardia
62%
Antiarrhythmic Agent
25%
Cardiac Dysrhythmia
12%
Premature Ventricular Contraction
12%